Disappointing results for ceperognastat in elevated Tau Patients
Eli Lily scientists report that ceperognastat, a putative treatment for Alzheimer’s Disease, did not provide any meaningful benefits in phase 2 clinical trials. The news isn’t all bad, however, the drug may have failed in clinical trials, but it still tells us something useful about how the disease works. Alzheimer’s specialists tested the drug, also known […]
The post Disappointing results for ceperognastat in elevated Tau Patients appeared first on Medical News Bulletin.








